Roy SE - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected].

Stein RC, Malkovska V, Morgan S, Galazka A, Aniszewski C, Roy SE, Shearer RJ, Marsden RA, Bevan D, Gordon-Smith EC, et al. Stein RC, et al. Among authors: roy se. Br J Cancer. 1991 Feb;63(2):275-8. doi: 10.1038/bjc.1991.64. Br J Cancer. 1991. PMID: 1997106 Free PMC article.

Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma.

Mattijssen V, De Mulder PH, Schornagel JH, Verweij J, Van den Broek P, Galazka A, Roy S, Ruiter DJ. Mattijssen V, et al. J Immunother (1991). 1991 Feb;10(1):63-8. doi: 10.1097/00002371-199102000-00009. J Immunother (1991). 1991. PMID: 2012800

Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.

Saif MW, Black G, Roy S, Bell D, Russo S, Eloubeidi MA, Steg A, Johnson MR, Zelterman D, Diasio RB. Saif MW, et al. Cancer J. 2007 Jul-Aug;13(4):247-56. doi: 10.1097/PPO.0b013e31813c12b8. Cancer J. 2007. PMID: 17762760 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters